Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.

Pappert EJ, Germanson T; Myobloc/Neurobloc European Cervical Dystonia Study Group.

Mov Disord. 2008 Mar 15;23(4):510-7.

PMID:
18098274
2.

Botulinum toxin type B for cervical dystonia.

Costa J, Espírito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004315. Review. Update in: Cochrane Database Syst Rev. 2016;(5):CD004315.

PMID:
15674941
3.

Botulinum toxin type B for cervical dystonia.

Marques RE, Duarte GS, Rodrigues FB, Castelão M, Ferreira J, Sampaio C, Moore AP, Costa J.

Cochrane Database Syst Rev. 2016 May 13;(5):CD004315. doi: 10.1002/14651858.CD004315.pub3. Review.

PMID:
27176573
4.

Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.

Duarte GS, Castelão M, Rodrigues FB, Marques RE, Ferreira J, Sampaio C, Moore AP, Costa J.

Cochrane Database Syst Rev. 2016 Oct 26;10:CD004314. Review.

PMID:
27782297
5.
6.

Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.

Chapman MA, Barron R, Tanis DC, Gill CE, Charles PD.

Clin Ther. 2007 Jul;29(7):1325-37. Review.

PMID:
17825685
7.

Botulinum toxin therapy for cervical dystonia.

Jankovic J.

Neurotox Res. 2006 Apr;9(2-3):145-8. Review.

PMID:
16785112
8.

[Treatment of focal dystonia with botulinum toxin A].

Sojer M, Wissel J, Müller J, Poewe W.

Wien Klin Wochenschr. 2001;113 Suppl 4:6-10. Review. German.

PMID:
15506045
9.

Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.

Costa J, Borges A, Espírito-Santo C, Ferreira J, Coelho M, Moore P, Sampaio C.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004314. Review. Update in: Cochrane Database Syst Rev. 2016 Oct 26;10 :CD004314.

PMID:
15674940
10.

The safety and tolerability of botulinum toxins for the treatment of cervical dystonia.

Brashear A.

Expert Opin Drug Saf. 2005 Mar;4(2):241-9. Review.

PMID:
15794717
11.

Botulinum toxin type A therapy for cervical dystonia.

Costa J, Espírito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003633. Review.

PMID:
15674910
12.

Cervical dystonia: from pathophysiology to pharmacotherapy.

Patel S, Martino D.

Behav Neurol. 2013;26(4):275-82. doi: 10.3233/BEN-2012-120270. Review.

13.

Botulinum toxin treatment of axial and cervical dystonia.

Benecke R, Dressler D.

Disabil Rehabil. 2007 Dec 15;29(23):1769-77. Review.

PMID:
18033602
14.

The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part I): muscle afferent block versus botulinum toxin-A in cervical and limb dystonias.

Rosales RL, Santos MM, Ng AR, Teleg R, Dantes M, Lee LV, Fernandez HH.

Int J Neurosci. 2011;121 Suppl 1:35-43. doi: 10.3109/00207454.2010.544435. Epub 2011 Jan 19. Review.

PMID:
21244305
15.

Rating scales for cervical dystonia: a critical evaluation of tools for outcome assessment of botulinum toxin therapy.

Jost WH, Hefter H, Stenner A, Reichel G.

J Neural Transm (Vienna). 2013 Mar;120(3):487-96. doi: 10.1007/s00702-012-0887-7. Epub 2012 Aug 17. Review.

16.

Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.

Sycha T, Kranz G, Auff E, Schnider P.

J Neurol. 2004 Feb;251 Suppl 1:I19-30. Review.

PMID:
14991339
17.

The botulinum toxins in the treatment of cervical dystonia.

Brashear A.

Semin Neurol. 2001;21(1):85-90. Review.

PMID:
11346029
18.

Duration of effectiveness of botulinum toxin type B in the treatment of cervical dystonia.

Lew MF.

Adv Neurol. 2004;94:211-5. Review. No abstract available.

PMID:
14509675
19.

Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment.

Camargo CH, Cattai L, Teive HA.

Toxins (Basel). 2015 Jun 23;7(6):2321-35. doi: 10.3390/toxins7062321. Review.

20.

Supplemental Content

Support Center